BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28001320)

  • 1. Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor K
    Grøvik E; Redalen KR; Storås TH; Negård A; Holmedal SH; Ree AH; Meltzer S; Bjørnerud A; Gjesdal KI
    J Magn Reson Imaging; 2017 Jul; 46(1):194-206. PubMed ID: 28001320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.
    Bakke KM; Grøvik E; Meltzer S; Negård A; Holmedal SH; Mikalsen LTG; Lyckander LG; Ree AH; Gjesdal KI; Redalen KR; Bjørnerud A
    J Magn Reson Imaging; 2019 Oct; 50(4):1114-1124. PubMed ID: 30945379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
    Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
    Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences and Tumor Blood Flow from Dynamic Susceptibility Contrast MRI Are Associated with Treatment Response after Chemoradiation and Long-term Survival in Rectal Cancer.
    Bakke KM; Meltzer S; Grøvik E; Negård A; Holmedal SH; Gjesdal KI; Bjørnerud A; Ree AH; Redalen KR
    Radiology; 2020 Nov; 297(2):352-360. PubMed ID: 32870132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
    Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
    J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-parametric MRI of rectal cancer - do quantitative functional MR measurements correlate with radiologic and pathologic tumor stages?
    Attenberger UI; Pilz LR; Morelli JN; Hausmann D; Doyon F; Hofheinz R; Kienle P; Post S; Michaely HJ; Schoenberg SO; Dinter DJ
    Eur J Radiol; 2014 Jul; 83(7):1036-1043. PubMed ID: 24791649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
    Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
    J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
    Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
    J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of quantitative intravoxel incoherent motion parameters in the preoperative diagnosis of nodal metastasis in patients with rectal carcinoma.
    Qiu L; Liu XL; Liu SR; Weng ZP; Chen XQ; Feng YZ; Cai XR; Guo CY
    J Magn Reson Imaging; 2016 Oct; 44(4):1031-9. PubMed ID: 27019309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitating whole lesion tumor biology in rectal cancer MRI: taking a lesson from FDG-PET tumor metrics.
    Gollub MJ; Hotker AM; Woo KM; Mazaheri Y; Gonen M
    Abdom Radiol (NY); 2018 Jul; 43(7):1575-1582. PubMed ID: 29159523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Mesorectal Microcirculation With Quantitative Dynamic Contrast-Enhanced MRI.
    Yang X; Liu Y; Chen Y; Wen Z; Lin B; Quan X; Yu S
    AJR Am J Roentgenol; 2020 Dec; 215(6):1370-1376. PubMed ID: 32991218
    [No Abstract]   [Full Text] [Related]  

  • 17. Single bolus split dynamic MRI: Is the combination of high spatial and dual-echo high temporal resolution interleaved sequences useful in the differential diagnosis of breast masses?
    Grøvik E; Bjørnerud A; Kurz KD; Kingsrød M; Sandhaug M; Storås TH; Gjesdal KI
    J Magn Reson Imaging; 2015 Jul; 42(1):180-7. PubMed ID: 25211038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
    Wu J; Gong G; Cui Y; Li R
    J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.
    Yu J; Xu Q; Huang DY; Song JC; Li Y; Xu LL; Shi HB
    Eur Radiol; 2017 May; 27(5):1840-1847. PubMed ID: 27595835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.